Diagnostic performance of carbohydrate antigen 72-4 for gastrointestinal malignancy screening in Chinese patients: a prospective study

Shu-Ling Wang; Guan-Yu Yu; An-Rong Mao; Sheng-Bing Zhao; Hui-Yun Wang; Lun Gu; Dong Wang; Zhao-Shen Li; Yu Bai

doi:10.18632/oncotarget.22919

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Withdrawal Notice

This paper was originally published in Oncotarget Advance Online Publications on 12/05/2017.
In compliance with Oncotarget's withdrawal policy, the paper was withdrawn in its entirety. It will not appear in Oncotarget internal or any external indexes or archives.

Research Papers:

Diagnostic performance of carbohydrate antigen 72-4 for gastrointestinal malignancy screening in Chinese patients: a prospective study

Shu-Ling Wang, Guan-Yu Yu, An-Rong Mao, Sheng-Bing Zhao, Hui-Yun Wang, Lun Gu, Dong Wang _, Zhao-Shen Li and Yu Bai

Shu-Ling Wang1,*, Guan-Yu Yu2,*, An-Rong Mao3,*, Sheng-Bing Zhao1, Hui-Yun Wang4, Lun Gu1, Dong Wang1, Zhao-Shen Li1 and Yu Bai1

1Department of Gastroenterology, Changhai Hospital, Second Military Medical University/Naval Medical University, Shanghai, China

2Department of Colorectal Surgery, Changhai Hospital, Second Military Medical University/Naval Medical University, Shanghai, China

3Department of Hepatic Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China

4Department of Oncology, Affiliated Hospital of Qingdao University, Qingdao, China

*Co-first authors

Correspondence to:

Dong Wang, email: [email protected]

Zhao-Shen Li, email: [email protected]

Yu Bai, email: [email protected]

Keywords: CA72-4; malignancies; gastric cancer; prediction; diagnosis

Received: July 21, 2017 Accepted: November 03, 2017 Published: December 05, 2017

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 22919

Publication Alerts

Post-Publication Promotion

Publication Discount

Withdrawal Notice

Research Papers:

Diagnostic performance of carbohydrate antigen 72-4 for gastrointestinal malignancy screening in Chinese patients: a prospective study